» Articles » PMID: 17877537

The Mouse Mammary Carcinoma 4T1: Characterization of the Cellular Landscape of Primary Tumours and Metastatic Tumour Foci

Overview
Publisher Wiley
Specialty Pathology
Date 2007 Sep 20
PMID 17877537
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

The murine mammary carcinoma 4T1 causes a leukemoid reaction with profound granulocytosis coincident with the production of tumour-derived growth factors. Here, we study the evolving cellular landscape of primary tumours and metastatic tumour foci and correlate haematopoietic cell infiltration with the production of tumour-derived chemokines. Flow cytometric analysis of enzyme digested primary tumours at different times after transplantation revealed a progressively increasing CD45(+) haematopoietic cell infiltrate consisting predominantly of CD11b(+) myeloid cells. Most of these cells had an F4/80(+)/CD11c(+) phenotype, many of which also stained Gr-1(+). Smaller numbers of Gr-1(+)CD11b(+) granulocytes and lymphoid cells were also identified. Progressive increases in Gr-1(+) granulocytes were observed in enzymatic digests of livers and lungs with metastatic tumour foci. Cultured 4T1 tumour cells expressed mRNA transcripts for the myeloid cell chemokines RANTES, MCP-1 and KC, and enzymatically digested cells from primary 4T1 tumours partially depleted of CD45(+) cells expressed transcripts for these chemokines and also MIP-1alpha and MIP-1beta. These data demonstrate that 4T1 tumour-bearing mice have mixed myeloid cell infiltrates of primary tumours and granulocytic infiltrates of metastatic organs. This pathologic presentation correlated with the expression of tumour-derived chemokines.

Citing Articles

Canine, Feline, and Murine Mammary Tumors as a Model for Translational Research in Breast Cancer.

Cassali G, Nakagaki K, Salvi M, Dos Reys M, Rocha M, de Campos C Vet Sci. 2025; 12(2).

PMID: 40005948 PMC: 11860833. DOI: 10.3390/vetsci12020189.


Shortwave-Infrared-Emitting Nanoprobes for CD8 Targeting and In Vivo Imaging of Cytotoxic T Cells in Breast Cancer.

Shah J, Siebert J, Zhao X, He S, Riman R, Tan M Adv Nanobiomed Res. 2024; 4(2):2300092.

PMID: 39554690 PMC: 11566364. DOI: 10.1002/anbr.202300092.


Enhancing Anti-PD-1 Immunotherapy by Targeting MDSCs via Hepatic Arterial Infusion in Breast Cancer Liver Metastases.

Kim M, Powers C, Fisher D, Ku A, Neznanov N, Safina A Cancers (Basel). 2024; 16(21).

PMID: 39518148 PMC: 11545300. DOI: 10.3390/cancers16213711.


Bone mineral density affects tumor growth by shaping microenvironmental heterogeneity.

Whitman M, Mantri M, Spanos E, Estroff L, De Vlaminck I, Fischbach C Biomaterials. 2024; 315:122916.

PMID: 39490060 PMC: 11658005. DOI: 10.1016/j.biomaterials.2024.122916.


Screening and validating the optimal panel of housekeeping genes for 4T1 breast carcinoma and metastasis studies in mice.

Souza J, Antunes-Porto A, da Silva Oliveira I, Amorim C, Pires L, de Brito Duval I Sci Rep. 2024; 14(1):26476.

PMID: 39488625 PMC: 11531515. DOI: 10.1038/s41598-024-77126-x.


References
1.
Angulo I, De Las Heras F, Gargallo D, Munoz-Fernandez M, Fresno M . Nitric oxide-producing CD11b(+)Ly-6G(Gr-1)(+)CD31(ER-MP12)(+) cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice. Blood. 1999; 95(1):212-20. View

2.
Fleming T, Fleming M, Malek T . Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J Immunol. 1993; 151(5):2399-408. View

3.
Bronte V, Apolloni E, Cabrelle A, Ronca R, Serafini P, Zamboni P . Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. Blood. 2000; 96(12):3838-46. PMC: 2734459. View

4.
Almand B, Clark J, Nikitina E, Van Beynen J, English N, Knight S . Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol. 2000; 166(1):678-89. DOI: 10.4049/jimmunol.166.1.678. View

5.
Di Carlo E, Forni G, Lollini P, Colombo M, Modesti A, Musiani P . The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood. 2001; 97(2):339-45. DOI: 10.1182/blood.v97.2.339. View